Evidence map›Paper›PMID 25583527›Full record

ArticleInfection and immunity2015

MyD88-dependent signaling drives host survival and early cytokine production during Histoplasma capsulatum infection.

Alison Coady, Anita Sil

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Alison CoadyDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA.
Anita SilDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, California, USA sil@cgl.ucsf.edu.
Howard Hughes Medical Institute · USUniversity of California, San Francisco · US

Funding

The role of Listeria cyclic-di-AMP during infection and immunityP01AI063302 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI STANLEY, SARAH A · 2004 to 2025
$45.5M
Molecular dissection of Histoplasma-induced host-cell deathR01AI093640 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SIL, ANITA · 2012 to 2015
$1.6M
Howard Hughes Medical InstituteNIAID NIH HHS P01 AI063302NIAID NIH HHS P01AI063302NIAID NIH HHS R01 AI093640NIAID NIH HHS R01AI093640
6 · The paper itself

Abstract

The ability of the innate immune system to trigger an adaptive T cell response is critical to resolution of infection with the fungal pathogen Histoplasma capsulatum. However, the signaling pathways and cell types involved in the recognition of and response to this respiratory pathogen remain poorly defined. Here, we show that MyD88, an adaptor protein vital to multiple innate immune pathways, is critically required for the host response to Histoplasma. MyD88-deficient (MyD88-/-) mice are unable to control the fungal burden and are more sensitive to Histoplasma infection than wild-type, Dectin-1-/-, or interleukin 1 receptor-deficient (IL-1R-/-) mice. We found that MyD88 is necessary for the production of key early inflammatory cytokines and the subsequent recruitment of inflammatory monocytes to the lung. In both our in vitro and ex vivo analyses, MyD88 was intrinsically required in dendritic cells and alveolar macrophages for initial cytokine production. Additionally, MyD88-deficient bone marrow-derived dendritic cells fail to efficiently control fungal growth when cocultured with primed splenic T cells. Surprisingly, mice that lack MyD88 only in dendritic cells and alveolar macrophages are competent for early cytokine production and normal survival, indicating the presence of compensatory and redundant MyD88 signaling in other cell types during infection. Ultimately, global MyD88 deficiency prevents proper T cell activation and gamma interferon (IFN-γ) production, which are critical for infection resolution. Collectively, this work reveals a central role for MyD88 in coordinating the innate and adaptive immune responses to infection with this ubiquitous fungal pathogen of humans.

Indexed as

Adaptive ImmunityImmunity, InnateAnimalsBone Marrow CellsCD4-Positive T-LymphocytesCells, CulturedCytokinesDectin-1Dendritic CellsFemaleHistoplasmaHistoplasmosisInflammationInterferon-gammaLectins, C-TypeLungCytokinesDectin-1Interferon-gammaLectins, C-TypeMyd88 protein, mouseMyeloid Differentiation Factor 88Receptors, Interleukin-1

Identifiers

PMID25583527
PMCPMC4363404
OpenAlexW2102744934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.